Alpha-thalassemia
What's New
Last Posted: May 16, 2023
- Prevalence of Thalassemia in the Vietnamese Population and Building a Clinical Decision Support System for Prenatal Screening for Thalassemia.
Danh Cuong Tran et al. Mediterr J Hematol Infect Dis 2023 15(1) e2023026 - An analysis of the distribution and spectrum of alpha thalassemia mutations in Rasht City, North of Iran.
Mona Asghari Ahmadabad et al. Front Pediatr 2023 111039148 - Rapid Targeted Sequencing Using Dried Blood Spot Samples for Patients With Suspected Actionable Genetic Diseases.
Kim Man Jin et al. Annals of laboratory medicine 2022 43(3) 280-289 - Mutations in Thalassemia Carrier Couples: The Importance of Prenatal Diagnostic Tests.
Kiani Ali Asghar et al. Clinical laboratory 2022 68(5) - Erythrocyte Indices and Hemoglobin Analysis for α-Thalassemia Screening in an Area with High Carrying Rate.
Zheng Lin et al. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2022 38(2) 352-358 - Newborn Screening and Clinical Profile of Children with Sickle Cell Disease in a Tribal Area of Gujarat.
Dave Kapil Kumar et al. Indian pediatrics 2022 - Screening of Some Indicators for Alpha-Thalassemia in Fujian Province of Southern China.
Zheng Lin et al. International journal of general medicine 2021 147329-7335 - Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central Malawi.
Tegha Gerald et al. International journal of public health 2021 66629338 - Genetic epidemiology of hemoglobinopathies among Iraqi Kurds.
Al-Allawi Nasir et al. Journal of community genetics 2020 Nov - Study Finds Methods for Alpha-Thalassemia Screening and Reporting Vary Across Newborn Screening Programs
CDC, September 2020 - Newborn Screening Practices and Alpha-Thalassemia Detection - United States, 2016.
Bender M A et al. MMWR. Morbidity and mortality weekly report 2020 Sep 69(36) 1269-1272 - Newborn Screening Practices and Alpha-Thalassemia Detection — United States, 2016
MA Bender et al, MMWR, September 11, 2020 - Genetic testing costs and compliance with clinical best practices.
Montanez Kathleen et al. Journal of genetic counseling 2020 May - [Clinical practice guidelines for alpha-thalassemia].
Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association et al. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020 Mar 37(3) 235-242 - Expanded carrier screening for preconception reproductive risk assessment: Prevalence of carrier status in a Mexican population.
Hernandez-Nieto Carlos et al. Prenatal diagnosis 2020 Jan - Sickle cell screening in Uganda: High burden, human immunodeficiency virus comorbidity, and genetic modifiers.
Kiyaga Charles et al. Pediatric blood & cancer 2019 May e27807 - Genetic, laboratory and clinical risk factors in the development of overt ischemic stroke in children with sickle cell disease.
Belisário André Rolim et al. Hematology, transfusion and cell therapy 40(2) 166-181 - Clinical experience with multigene carrier panels in the reproductive setting.
Terhaar Catherine et al. Prenatal diagnosis 2018 Apr - Variability in State-Based Recommendations for Management of Alpha Thalassemia Trait and Silent Carrier Detected on the Newborn Screen.
Fogel Benjamin N et al. The Journal of pediatrics 2017 Dec - A Pilot Study of Noninvasive Prenatal Diagnosis of Alpha- and Beta-Thalassemia with Target Capture Sequencing of Cell-Free Fetal DNA in Maternal Blood.
Wang Wenjuan et al. Genetic testing and molecular biomarkers 2017 Jul 21(7) 433-439
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 25, 2024
- Content source: